Comments
Loading...

Axsome Therapeutics

AXSMNASDAQ
Logo brought to you by Benzinga Data
$94.10
2.562.80%
Last update: 10:42 AM
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$180.00
Lowest Price Target1
$49.00
Consensus Price Target1
$114.55

Axsome Therapeutics (NASDAQ:AXSM) Stock, Analyst Ratings, Price Targets, Forecasts

Axsome Therapeutics Inc has a consensus price target of $114.55 based on the ratings of 20 analysts. The high is $180 issued by HC Wainwright & Co. on September 5, 2024. The low is $49 issued by Mizuho on May 3, 2022. The 3 most-recent analyst ratings were released by Cantor Fitzgerald on September 16, 2024, September 9, 2024, and September 6, 2024, respectively. With an average price target of $107 between Cantor Fitzgerald, there's an implied 13.71% upside for Axsome Therapeutics Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
May
1
Jun
2
1
Jul
1
Aug
4
Sep
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Cantor Fitzgerald
HC Wainwright & Co.
Needham
Wells Fargo
UBS

1calculated from analyst ratings

Analyst Ratings for Axsome Therapeutics

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Axsome Therapeutics (AXSM) stock?

A

The latest price target for Axsome Therapeutics (NASDAQ:AXSM) was reported by Cantor Fitzgerald on September 16, 2024. The analyst firm set a price target for $107.00 expecting AXSM to rise to within 12 months (a possible 13.71% upside). 51 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Axsome Therapeutics (AXSM)?

A

The latest analyst rating for Axsome Therapeutics (NASDAQ:AXSM) was provided by Cantor Fitzgerald, and Axsome Therapeutics reiterated their overweight rating.

Q

When was the last upgrade for Axsome Therapeutics (AXSM)?

A

The last upgrade for Axsome Therapeutics Inc happened on August 6, 2024 when B of A Securities raised their price target to $106. B of A Securities previously had a neutral for Axsome Therapeutics Inc.

Q

When was the last downgrade for Axsome Therapeutics (AXSM)?

A

There is no last downgrade for Axsome Therapeutics.

Q

When is the next analyst rating going to be posted or updated for Axsome Therapeutics (AXSM)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Axsome Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Axsome Therapeutics was filed on September 16, 2024 so you should expect the next rating to be made available sometime around September 16, 2025.

Q

Is the Analyst Rating Axsome Therapeutics (AXSM) correct?

A

While ratings are subjective and will change, the latest Axsome Therapeutics (AXSM) rating was a reiterated with a price target of $107.00 to $107.00. The current price Axsome Therapeutics (AXSM) is trading at is $94.10, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch